Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients.

Hussein Al JoboriGiuseppe DanieleJohn AdamsEugenio CersosimoCurtis TriplittRalph A DeFronzoMuhammad A Abdul-Ghani

Published in: Diabetes, obesity & metabolism (2017)

Results of the present study demonstrate that SGLT2 inhibition exerts different metabolic effects in non-diabetic individuals as compared to diabetic patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
type diabetes
peritoneal dialysis
prognostic factors
adipose tissue
wound healing
patient reported